CHICAGO, IL—Use of the Sentinel Cerebral Protection System (Claret Medical), a filter device employed during transcatheter aortic valve replacement procedures, significantly reduces the risk of ...

WASHINGTON, A multicenter randomized trial evaluating the role of embolic protection using the Sentinel device during transcatheter aortic valve replacement (TAVR) found that the device was safe but ...

SANTA ROSA, Calif.--(BUSINESS WIRE)--Claret Medical® today announced publication of a new study in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions that ...

WASHINGTON -- An embolic protection device deployed during transcatheter aortic valve replacement (TAVR) caught plenty of material but without any impact on subclinical or clinical outcomes, the ...

Please provide your email address to receive an email when new articles are posted on . Adults who underwent transcatheter aortic valve replacement with a cerebral protection system experienced fewer ...

WASHINGTON, DC — An embolic-protection device delivered percutaneously via the radial artery and used during transcatheter aortic-valve implantation (TAVI) in high-risk patients with aortic stenosis ...

CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within ...

Click here for the video animation of the ProtEmbo ® System AACHEN, Germany–(BUSINESS WIRE)–September 5, 2017– Protembis GmbH, a privately held medical device company, announced today the first ...

Please provide your email address to receive an email when new articles are posted on . How many randomized clinical trials of parachutes vs. no parachutes are there? The answer, of course, is none.

DUBLIN, Oct. 9, 2020 /PRNewswire/ -- The "Embolic Protection Devices Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The market is growing ...

The REFLECT II randomized clinical trial evaluating the safety and efficacy of a device designed to reduce cerebral embolization and ischemic stroke, complications of transcatheter aortic valve ...